本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Janux Therapeutics, Inc.

26.97
+0.10000.37%
成交量:9.80萬
成交額:266.51萬
市值:15.94億
市盈率:-21.01
高:28.00
開:26.87
低:26.02
收:26.87
資料載入中...
2024/09/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/09

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/07

重要事件披露

Form 8-K - Current report
2024/07/22

重要事件披露

Form 8-K - Current report
2024/06/28

重要事件披露

Form 8-K - Current report
2024/06/05

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/08

重要事件披露

Form 8-K - Current report
2024/03/08

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/08

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]